Euractiv (Advocacy Lab)
EU Perspectives
European Biotechnology Magazine
APM Market Access
EURACTIV - Global guidelines commit EU governments to make neurological conditions a national priority, yet epilepsy care still varies sharply across Europe. A recent report urges the EU to harmonise standards, embed epilepsy in its non-communicable disease policy, and build mental health into the standard epilepsy care budget. Read more
EURACTIV - Belgium's biotech sector has the science but not the scale, according to a new PwC whitepaper, which argues that the country must operate as one ecosystem if startups are to grow. Read more
EU PERSPECTIVES - Europe's share of global clinical trials has been cut in half in just a decade, while China has surged ahead. As Ireland takes over the EU presidency on Wednesday, Dublin is betting that faster drug approvals, biotech reforms and health investment can restore Europe's competitiveness — and determine how quickly patients get...
EURACTIV - Belgian Prime Minister Bart De Wever has told policymakers he wants to restart the R&D Biopharma platform after the summer. He played down talk of crisis, a day after warning – at the anniversary of Novartis's Puurs site in Belgium – that Europe is losing ground to the United States and China. Read more
